

Cover Story
Conversation with The Cancer LetterFree
In recent years, NCI spending on extramural research has been following the same trajectory as Congressional appropriations for the institute: up, up, up.
Free
By Claire Dietz and Matthew Bin Han Ong
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- The other side of the patient portal: Reflections from a cancer center leader
- RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”
- Surviving cancer is often not a patient’s most challenging battle
- We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James